ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 2 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $115,388 | -64.3% | 10,386 | +45.4% | 0.00% | – |
Q4 2022 | $323,620 | +7.2% | 7,144 | +24.4% | 0.00% | – |
Q3 2022 | $302,000 | -68.2% | 5,742 | -71.2% | 0.00% | -100.0% |
Q2 2022 | $950,000 | -35.4% | 19,972 | -1.7% | 0.00% | -50.0% |
Q1 2022 | $1,471,000 | +18.1% | 20,324 | +17.7% | 0.00% | +100.0% |
Q4 2021 | $1,246,000 | +83.0% | 17,269 | +45.1% | 0.00% | 0.0% |
Q3 2021 | $681,000 | +28.7% | 11,904 | -0.0% | 0.00% | 0.0% |
Q2 2021 | $529,000 | +142.7% | 11,906 | +126.0% | 0.00% | – |
Q4 2020 | $218,000 | -8.4% | 5,269 | +0.6% | 0.00% | – |
Q3 2020 | $238,000 | -76.6% | 5,236 | -74.2% | 0.00% | -100.0% |
Q2 2020 | $1,019,000 | +11.5% | 20,295 | +37.7% | 0.00% | 0.0% |
Q4 2019 | $914,000 | – | 14,740 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |